medline.ch Onkologie Gynäkologische Tumoren

	Copper complexes in the triple-negative breast cancer landscape: advances and opportunities. Front Mol Biosci Lima PMAP, de Matos ACP, Guimarães GDS, Barbosa LAS, Araújo TG. PMID: 42928858 [PubMed]
	A Retrospective Study Analysing the Outcomes of Anxiety, Depression, and Sleep Disorders in Post-Chemotherapy Patients With Breast Cancer Based on Symptom-Targeted Supportive Psychological Nursing. Actas Esp Psiquiatr Shi Y, Zhou Y, Yan J, Zhao R, Zhang Q, Xu J. PMID: 42928681 [PubMed - indexed for MEDLINE]
	Vaginal Angiomyofibroblastoma in a Patient With Warkany Syndrome (Mosaic Trisomy 8): A Case Report. J Obstet Gynaecol Res Amaireh EA, Marahleh M, Al-Hussaini M, Mahfouz IA. PMID: 42928509 [PubMed - indexed for MEDLINE]
	Use of hair relaxers and hair dyes during pregnancy and breast tissue composition in mothers and adolescent daughters. Breast Cancer Res Chan M, Lilge L, Walter J, Tehranifar P, Miller RL, Hoang A, Shephard P, Perera F, Herbstman JB, Terry MB, McDonald JA, Kehm RD. PMID: 42928199 [PubMed - indexed for MEDLINE]
	A novel Hemoglobin-Albumin-Lymphocyte-Platelet (HALP)-based prognostic model to predict the progression of premenopausal breast cancer: a retrospective cohort study. BMC Cancer Zhang S, Xu L, Peng W. PMID: 42928141 [PubMed - indexed for MEDLINE]
	The Role of Self-Collection in Optimising Cervical Screening for People With Intellectual Disability: A Multi Perspective Qualitative Study. Health Expect Winkler L, Power R, Allison KR, Strnadová I, Carter A, Ussher J, Jolly H, Basckin C, Sweeney S, Loblinzk J, Bateson D. PMID: 42927653 [PubMed - indexed for MEDLINE]
	Molecular mechanisms and targeted therapeutic strategies of TIGAR in regulating energy metabolism to promote tumor proliferation in breast cancer. Breast Cancer Zhai M, Wang P, Ou Y. PMID: 42927599 [PubMed - as supplied by publisher]
	Evaluation of FGFR2, VEGFA, and MMP1 gene variants for ovarian cancer susceptibility among South Indian women: a hospital-based case-control study. Mol Biol Rep Canchi Sistla H, Seshachalam A, Rathnam KK, Rajagopal T, Talluri S, Venkatabalasubramanian S, Dunna NR. PMID: 42927554 [PubMed - indexed for MEDLINE]
	Development and Validation of a Lipid Metabolism-Related Gene Prognostic Model for Breast Cancer: Integrating Risk Score and Nomogram. Breast Care (Basel) Yin Y, Yan J, Wang J, Yuan M. PMID: 42927407 [PubMed - as supplied by publisher]
	Timing of cranial radiotherapy in HER2-positive breast Cancer brain metastases treated with Pyrotinib: a multicentre real-world cohort study. Clin Transl Radiat Oncol Chen Z, Jing H, Huang S, Wang M, Mao D, Li L, Lu S, Zhou X, Bi D, Zhang Y, Chen X, Ma Y, Xia Y, Yi J, Hou Y. PMID: 42927325 [PubMed]
	A HALF CENTURY OF PROGRESS IN BREAST CANCER: WHERE DO WE GO NEXT? Trans Am Clin Climatol Assoc Winer EP. PMID: 42927318 [PubMed - indexed for MEDLINE]
	Baseline prevalence of lung cancer screening and associated factors among women in breast cancer screening clinics prior to the Pink & Pearl program: A retrospective analysis of electronic health records. Res Sq Odeny B, Ramaswamy SG, Bowe B, Zewde E, Mnatzakanian A, Akinloye B, Odeny T, Lee MV. PMID: 42926932 [PubMed]
	Thrombotic Risk of Targeted Therapies in Breast Cancer: A Real-World Cohort Study. Res Sq Boland W, Guzik G, Grinsztejn E, Perez JA, Plevniak K, Bannow BS, Nayak L, Martin J. PMID: 42926660 [PubMed]
	Menopause timing, hormone therapy, epigenetic aging, and breast cancer outcomes: a secondary analysis of the PLCO Cancer Screening Trial. medRxiv Zhai T, Pankratz VS, Zychowski KE, Li Y, Leslie KK, Guo Y, Amos CI, Cook LS, Leng S. PMID: 42926595 [PubMed]
	Pembrolizumab Plus Chemotherapy for HR+/HER2- PD-L1â€’Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study. Ann Oncol Rugo HS, Kok M, Goncalves A, Loirat D, Bianchini G, Fasching PA, Cescon DW, Díaz RR, Zagouri F, Korbenfeld E, Dalenc F, Gilarranz YJ, Hashimoto J, Park YH, Im SA, Hu X, Hirshfield KM, Jia L, Tryfonidis K, Schmid P. PMID: 42926111 [PubMed - as supplied by publisher]
	Atirmociclib and fulvestrant for patients with HR+/HER2- advanced/metastatic breast cancer who progressed on a prior cyclin-dependent kinase 4/6 inhibitor: primary analysis of the randomized FourLight-1 trial. Ann Oncol Giordano A, Xu B, Yoshinami T, Huang CS, Park YH, Lerzo GL, Li H, Shai A, Jaliffe GG, Itoh M, Williams A, Goel S, Im SA, Cobb P, Golmakani M, Liu F, Moss RA, Vana A, Ignatiadis M, Rugo HS. PMID: 42926110 [PubMed - as supplied by publisher]
	Overall survival from the phase III postMONARCH trial of abemaciclib plus fulvestrant versus placebo plus fulvestrant for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy. Ann Oncol Kalinsky K, Wander SA, Hamilton E, Graff SL, Jeselsohn R, Park KH, Demirci U, Martin M, Layman RM, Hurvitz SA, Sammons S, Kaufman PA, Ravenberg E, Amdur S, Litchfield LM, Bianchini G. PMID: 42926108 [PubMed - as supplied by publisher]
	Efficacy of an AIMP1-Derived Peptide (NeoPep-S) for Radiation-Induced Dermatitis in Breast Cancer Patients: A Prospective Randomized Active-Controlled Trial. Aesthetic Plast Surg Kim MJ, Kim HG, Han HM, Lim HS, Park YJ, Lee IJ. PMID: 42925326 [PubMed - as supplied by publisher]
	Screening Digital Breast Tomosynthesis Performance across Age Groups: Analysis of 302â€‰700 Examinations. Radiol Imaging Cancer Lamb LR, Mercaldo S, Destounis S, Bahl M. PMID: 42925141 [PubMed - indexed for MEDLINE]
	Trastuzumab Rezetecan in ERBB2-Low Advanced Breast Cancer: The HORIZON-Breast06 Randomized Clinical Trial. JAMA Fan Y, Liu Y, Wang Y, Ouyang Q, Zhang Q, Cui J, Li J, Ding Q, Wu X, Wang X, Tong Z, Zeng Y, Wang W, Yan M, Wang Y, Liu X, Li K, Sun Z, Yuan C, Wang T, Xie W, Yao J, Zhou S, Hou J, Ouyang Z, Li Y, Cui S, Zhang X, Zhu X, Xu B. PMID: 42925007 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 337012

Seite 1 von 16851

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung